1-11 of 11
Oleg Shukhov, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy

Anna G Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD, Evgeniya Shatokhina, MD PhD, Oleg Shukhov, MD PhD, Ekaterina Chelysheva, MD PhD, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Dzhariyat Shikhbabaeva, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver G. Ottmann, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 790.
https://doi.org/10.1182/blood-2018-99-116803
Published: 2018
Journal Articles

Kinetics of the Leukemic Clone in Patients with Chronic Myeloid Leukemia during Pregnancy

Ekaterina Chelysheva, MD PhD, Jane Apperley, MB ChB MD, Elisabetta Abruzzese, Dong-Wook Kim, MD PhD, Konstantin Kotlyarchuk, Oleg Shukhov, MD PhD, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4254.
https://doi.org/10.1182/blood-2018-99-115984
Published: 2018
Journal Articles

Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Interim Results of Russian Prospective Multicenter Trial RU-SKI

Anna Petrova, MD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G Turkina, Prof., MD, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Zinkovskaya, Tatiana Ionova, DSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3023.
https://doi.org/10.1182/blood-2018-99-113360
Published: 2018
Journal Articles

Prognostic Model of Successful Tyrosine Kinase Inhibitors Discontinuation Based on the Russian RU-SKI Multicenter Prospective Study

Oleg Shukhov, MD PhD, Ekaterina Chelysheva, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Irina Nemchenko, MD PhD, Galina Gusarova, MD PhD, Eduard Gemdzhian, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2018-99-116321
Published: 2018
Journal Articles

Analysis of the Effectiveness of Maintenance Therapy By Imatinib in Patients with Pdgfra -Positive Neoplasm

Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD PhD, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1755.
https://doi.org/10.1182/blood-2018-99-116262
Published: 2018
Journal Articles

Copy Number Variations in Cytochromes and Glutathione-Transferases As Early Predictors of the Efficacy of Tyrosine Kinase Inhibitors in CML

Alexander V Lavrov, MD PhD, Oksana A Ustaeva, Elmira P Adilgereeva, Svetlana A Smirnikhina, Ekaterina Chelysheva, MD, Oleg Shukhov, MD, Yuriy V Shatokhin, Sergey V Mordanov, Anna G Turkina, Prof., MD, Sergey Kutsev
Journal: Blood
Blood (2016) 128 (22): 5457.
https://doi.org/10.1182/blood.V128.22.5457.5457
Published: 2016
Journal Articles

Impact of Simultaneous Presence of Additional Chromosome Aberrations and BCR-ABL1 Kinase Domain Mutations on Survival in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Mikhail Fominykh, MD, Vasily Shuvaev, MD, Irina Martynkevich, DSc, Oleg Shukhov, MD, Ekaterina Chelysheva, MD, Anna G Turkina, Prof., MD, Kudrat Abdulkadyrov, Prof., MD PhD
Journal: Blood
Blood (2016) 128 (22): 5437.
https://doi.org/10.1182/blood.V128.22.5437.5437
Published: 2016
Journal Articles

The Rate of Individual BCR-ABL Decline As an Optimized Predictor of Tyrosine Kinase Inhibitors Treatment Outcome in Chronic Phase CML Patients, Comparison with CML Prognostic Scores and Early Molecular Response Achievement

Mikhail Fominykh, MD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Grigory Tsaur, MDPhD, Natalya Bederak, Ekaterina Chelysheva, Oleg Shukhov, MD, Adhamjon Abdullaev, MD PhD, Vera Udaleva, MD, Regina Golovchenko, MD, Irina Zotova, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Ekaterina Petrova, Marina Ivanova, Lyudmila Martynenko, Elizaveta Kleina, Natalya Cybakova, Anna Turkina, Prof., MD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5150.
https://doi.org/10.1182/blood.V126.23.5150.5150
Published: 2015
Journal Articles

Long-Term Results and Characteristics of Pleural Effusion in Late Chronic Phase Chronic Myeloid Leukemia Patients at Dasatinib Therapy after Imatinib Failure

Galina Gusarova, MD PhD, Anastasia Bykova, MD, Alexandra Vorontsova, MD PhD, Sergey Kuznetsov, MD, Oleg Shukhov, MD, Ekaterina Chelysheva, MD PhD, Olga Lazareva, MD PhD, Svetlana Goryacheva, MD PhD, Tatyana Ivanova, MD PhD, Anna G. Turkina, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5141.
https://doi.org/10.1182/blood.V126.23.5141.5141
Published: 2015
Journal Articles

Alterations in the Physiology of Multipotent Mesenchymal Stromal Cells from the Bone Marrow of Patients with Leukemia

Tamara Sorokina, MD, Irina Shipounova, PhD, Alexey Bigildeev, PhD, Nataliya Petinati, PhD, Nina I. Drize, PhD, Anna Turkina, Prof., MD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD
Journal: Blood
Blood (2015) 126 (23): 4768.
https://doi.org/10.1182/blood.V126.23.4768.4768
Published: 2015
Journal Articles

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Anna G. Turkina, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Vasiliy Shuvaev, Galina Gusarova, MD PhD, Anastasia Bykova, MD, Olga V. Lazareva, PhD, Oleg Shukhov, MD, Adham Abdullaev, MD PhD, Irina Martynkevich, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 5518.
https://doi.org/10.1182/blood.V124.21.5518.5518
Published: 2014